ATE438385T1 - Pharmazeutische zusammensetzung - Google Patents
Pharmazeutische zusammensetzungInfo
- Publication number
- ATE438385T1 ATE438385T1 AT06709975T AT06709975T ATE438385T1 AT E438385 T1 ATE438385 T1 AT E438385T1 AT 06709975 T AT06709975 T AT 06709975T AT 06709975 T AT06709975 T AT 06709975T AT E438385 T1 ATE438385 T1 AT E438385T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- microparticle
- pharmaceutical composition
- production
- ifn
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000011859 microparticle Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 102000006992 Interferon-alpha Human genes 0.000 abstract 1
- 108010047761 Interferon-alpha Proteins 0.000 abstract 1
- 229920002988 biodegradable polymer Polymers 0.000 abstract 1
- 239000004621 biodegradable polymer Substances 0.000 abstract 1
- 210000004443 dendritic cell Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 abstract 1
- 229920002477 rna polymer Polymers 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0504276A GB0504276D0 (en) | 2005-03-02 | 2005-03-02 | Pharmaceutical composition |
| GB0511801A GB0511801D0 (en) | 2005-06-10 | 2005-06-10 | Pharmaceutical composition |
| PCT/GB2006/000751 WO2006092607A1 (en) | 2005-03-02 | 2006-03-02 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE438385T1 true ATE438385T1 (de) | 2009-08-15 |
Family
ID=36353665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06709975T ATE438385T1 (de) | 2005-03-02 | 2006-03-02 | Pharmazeutische zusammensetzung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20080138431A1 (https=) |
| EP (1) | EP1853227B1 (https=) |
| JP (1) | JP2008531672A (https=) |
| AT (1) | ATE438385T1 (https=) |
| AU (1) | AU2006219717B2 (https=) |
| CA (1) | CA2599329A1 (https=) |
| DE (1) | DE602006008278D1 (https=) |
| WO (1) | WO2006092607A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3006043B1 (en) | 2002-04-04 | 2019-05-29 | Zoetis Belgium S.A. | Immunostimulatory g,u-containing oligoribonucleotides |
| JP4538522B2 (ja) | 2005-11-25 | 2010-09-08 | コーリー ファーマシューティカル ゲーエムベーハー | 免疫刺激性オリゴリボヌクレオチド |
| EP2711021B1 (en) * | 2008-05-02 | 2016-03-09 | BliNK Therapeutics Limited | Products and methods for stimulating an immune response |
| ES2557382T3 (es) | 2010-07-06 | 2016-01-25 | Glaxosmithkline Biologicals Sa | Liposomas con lípidos que tienen un valor de pKa ventajoso para el suministro de ARN |
| EP2591114B1 (en) | 2010-07-06 | 2016-06-08 | GlaxoSmithKline Biologicals SA | Immunisation of large mammals with low doses of rna |
| US9770463B2 (en) * | 2010-07-06 | 2017-09-26 | Glaxosmithkline Biologicals Sa | Delivery of RNA to different cell types |
| ES2646669T3 (es) | 2010-07-06 | 2017-12-14 | Glaxosmithkline Biologicals Sa | Procedimientos de aumento de una respuesta inmunitaria mediante el suministro de ARN |
| MX342608B (es) | 2010-07-06 | 2016-10-06 | Novartis Ag * | Particulas de suministro similares a viriones para moleculas de arn de autorreplicacion. |
| LT4226941T (lt) | 2010-08-31 | 2025-01-10 | Glaxosmithkline Biologicals Sa | Pegilintos liposomos, skirtos imunogeną koduojančios rnr pristatymui |
| WO2012051211A2 (en) | 2010-10-11 | 2012-04-19 | Novartis Ag | Antigen delivery platforms |
| EP2729165B1 (en) | 2011-07-06 | 2017-11-08 | GlaxoSmithKline Biologicals SA | Immunogenic combination compositions and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY118835A (en) * | 1997-04-18 | 2005-01-31 | Ipsen Pharma Biotech | Sustained release compositions and the process for their preparation |
| EP1438323A4 (en) * | 2001-10-03 | 2007-08-01 | Novartis Vaccines & Diagnostic | ADJUVOUS MENINGOCOCCUS COMPOSITIONS |
| CN101863930A (zh) * | 2003-01-06 | 2010-10-20 | 科里克萨有限公司 | 一些氨烷基氨基葡糖苷磷酸酯化合物和它们的用途 |
| WO2004087877A2 (en) * | 2003-03-26 | 2004-10-14 | Astral Inc. | Selected rna motifs to include cell death and/or apoptosis |
-
2006
- 2006-03-02 US US11/885,538 patent/US20080138431A1/en not_active Abandoned
- 2006-03-02 AU AU2006219717A patent/AU2006219717B2/en not_active Ceased
- 2006-03-02 AT AT06709975T patent/ATE438385T1/de not_active IP Right Cessation
- 2006-03-02 CA CA002599329A patent/CA2599329A1/en not_active Abandoned
- 2006-03-02 JP JP2007557589A patent/JP2008531672A/ja active Pending
- 2006-03-02 DE DE602006008278T patent/DE602006008278D1/de not_active Expired - Lifetime
- 2006-03-02 WO PCT/GB2006/000751 patent/WO2006092607A1/en not_active Ceased
- 2006-03-02 EP EP06709975A patent/EP1853227B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20080138431A1 (en) | 2008-06-12 |
| EP1853227A1 (en) | 2007-11-14 |
| WO2006092607A1 (en) | 2006-09-08 |
| AU2006219717B2 (en) | 2009-05-21 |
| JP2008531672A (ja) | 2008-08-14 |
| DE602006008278D1 (de) | 2009-09-17 |
| EP1853227B1 (en) | 2009-08-05 |
| CA2599329A1 (en) | 2006-09-08 |
| AU2006219717A1 (en) | 2006-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Devi VK et al. | Self-healing hydrogels: preparation, mechanism and advancement in biomedical applications | |
| Yu et al. | Smart polymeric nanoparticles in cancer immunotherapy | |
| Rizwan et al. | pH sensitive hydrogels in drug delivery: Brief history, properties, swelling, and release mechanism, material selection and applications | |
| Shi et al. | An antifouling hydrogel containing silver nanoparticles for modulating the therapeutic immune response in chronic wound healing | |
| WO2007040469A3 (en) | Chloroquine coupled compositions and methods for their synthesis | |
| Pahwa et al. | Chitosan-based gastroretentive floating drug delivery technology: an updated review | |
| ATE424848T1 (de) | Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen | |
| MX2009005727A (es) | Nanoparticulas de entidad anfifilica. | |
| WO2008013785A3 (en) | Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening | |
| WO2006060723A3 (en) | Methods for producing block copolymer/amphiphilic particles | |
| WO2004032862A3 (en) | Cyclodextrin-based materials, compositions and uses related thereto | |
| TW200635618A (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
| ATE438385T1 (de) | Pharmazeutische zusammensetzung | |
| EA201171279A1 (ru) | Производство инкапсулированных наночастиц с высокой объемной долей | |
| GEP20115200B (en) | Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same | |
| EA201170039A1 (ru) | Полимерные частицы, нагруженные лекарственным средством, и способы их получения и применения | |
| DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
| EA200900572A1 (ru) | Мицеллярные наночастицы с химическими субстанциями | |
| ZA200803350B (en) | Method of acting upon organism by targeted delivery of biologically active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose | |
| ATE459345T1 (de) | Wirkstoffpartikelhaltiges transdermales therapeutisches system mit erhöhtem wirkstofffluss | |
| WO2008085556A3 (en) | Surfactant-free nanoparticles for drug delivery | |
| Wang et al. | Injectable, adhesive albumin nanoparticle-incorporated hydrogel for sustained localized drug delivery and efficient tumor treatment | |
| WO2005055980A3 (en) | Polymalic acid-based multifunctional drug delivery system | |
| WO2023129738A3 (en) | Modified polysaccharide polymers and related compositions and methods thereof | |
| WO2006137856A3 (en) | Method for the production of nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |